Business Context and Reporting Period
This Form 8-K Current Report was filed by MacroGenics, Inc. on March 10, 2016, covering events occurring on March 8, 2016. The filing addresses Item 5.02 regarding the appointment of certain officers and their compensatory arrangements.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive compensation terms rather than financial performance metrics.
Material Changes
Effective March 8, 2016, the Company entered into an Employment Agreement with Ezio Bonvini, M.D., appointing him as Senior Vice President, Research. The Board of Directors approved the terms of this agreement.
Guidance, Outlook, and Management Commentary
The filing details the compensation structure for Dr. Bonvini:
- Annual Base Salary: $360,500
- Performance Bonus: Target opportunity of up to 35% of base salary
- Related Party Transactions: None disclosed; no family relationships with directors or other officers.
The filing contains no guidance, outlook, risk factors, or discussion of unusual items beyond the executive appointment.
Investor Verification Checklist
- Confirm the effective date of Dr. Bonvini's appointment as Senior Vice President, Research.
- Verify the approved base salary of $360,500 and the 35% bonus target.
- Review the Board of Directors' approval records for this specific employment agreement.